Skip to content
drillr.ai
Sign up

MAIA

MAIA Biotechnology, Inc.

US

—
Ask drillr

  • Jun 3, 2026, 13:45 UTC

    MAIA Biotechnology received FDA clearance to open U.S. enrollment in the ongoing Phase 2 THIO-101 trial expansion for its lead candidate ateganosine.

    Source: